Researchers Match Supplement Ingredients With Foreign Prescriptions
This article was originally published in The Tan Sheet
A study by researchers including Pieter Cohen, a critic of US supplement industry regulation, looks at the use of vinpocetine and picamilon in supplements and “demonstrates that some pharmaceutical drugs prescribed in other countries are sold openly in dietary supplements” in the US.
You may also be interested in...
Supplement industry stakeholders say FDA makes an unjustifiable regulatory move by stating that the widely used dietary supplement ingredient is noncompliant, while the finding compels the agency to reverse its earlier acceptance of NDI notifications for vinpocetine.
COVID-19 has disrupted the operational schedules of health care and technology providers alike to unparalleled levels in 2020. But scratch the surface, and outcomes-oriented, value-based health care targets remains a priority – albeit competing a little harder for attention at present.
In the latest instalment of VC Playbook, In Vivo gets to know Arix Bioscience, a relatively young venture capital firm that went public in 2016. Arix has “has many similarities yet some key differences from a typical venture capital firm,” says the management team.